What is ARWR's dilution risk score?

ARWR currently has a DilutionScore of 13/100, indicating low dilution risk. DilutionWatch monitors ARWR SEC filings in real-time, scanning EDGAR every 60 seconds for shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals.

What SEC filings does DilutionWatch track for ARWR?

DilutionWatch tracks 25 SEC filing types for ARWR including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect ARWR shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For ARWR, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for ARWR tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for ARWR. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

ARWR Dilution Risk Score: 13/100 (LOW)

📊 Score Breakdown

📋 Offering Ability

22

💰 Cash Runway

0

📊 Float Risk

2

⚠️ Warrant Exposure

15

🔄Convertible Debt—

🌦️ Dilution Forecast

☀️

Clear

No significant dilution signals

7%

🔁 Convertible Conversion 15%

• Convertible debt present: 6.4% potential dilution

🔔 Track ARWR — Get forecast alerts →

💹 Market Data

Market Cap$10.97B

Shares Outstanding140.86M

Float122.78M

Cash$1.66B

Debt$1.38B

Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 25.8% shares (2026Q1 vs prior)

441 institutional holders · 152.53M shares

#1 Avoro Capital Advisors LLC 21.32M shares

#2 BlackRock, Inc. 18.16M shares

#3 VANGUARD CAPITAL MANAGEMENT LLC 12.06M shares

+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest8.43M

Days to Cover2.2

% of Float6.9%

FINRA data as of Jun 30, 2026

👤 Insider Buy/Sell Ratio

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Mar 31, 2026

xbrl XBRL WARRANT Sep 30, 2025

4 INSIDER TRANSACTION Mar 09, 2026

Full SEC filing analysis available with free account →

📰 Recent News

No recent news

📋 What This Means for ARWR Shareholders

Arrowhead Pharmaceuticals, Inc. (ARWR) has a DilutionScore of 13/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 14, 2026.

DilutionWatch tracks 917,441 outstanding warrants for ARWR. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window.

DilutionWatch tracks over 25 SEC filing types for ARWR in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for ARWR alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Warrants Explained →